NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 14 மணி நேரத்திற்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Pelatro Board approves allotment of convertible warrants worth ₹27.40 Cr at ₹400 each
Pelatro Limited's Board has approved the allotment of 6,85,000 convertible share warrants at an issue price of ₹400 per warrant, aggregating up to ₹27.40 crore. The company has received 25% of the total consideration (₹6.85 crore), with the remaining 75% payable upon conversion within 18 months. The warrants are allotted to 9 allottees across promoter and public categories, with promoters Varun Menon and Kiran Menon subscribing to 2,00,000 warrants (₹8.0 crore). The total fundraising represents approximately 19.4% of the company's TTM revenue of ₹141 crore and 30.4% of its net worth of ₹90 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard formally allotted 6,85,000 convertible share warrants to 9 investors following receipt of 25% upfront application money.
ஏன் இது முக்கியம்Provides immediate capital infusion of ₹6.85 crore and an eventual ₹27.40 crore to bolster the balance sheet and support business growth initiatives.
Total fundraise value: Rs. 27,40,00,000/-Upfront consideration received (25%): Rs. 6,85,00,000/-Warrant issue price: Rs. 400/-Warrants allotted: 6,85,000Fundraise vs Net Worth: ~30.4%Fundraise vs TTM Revenue: ~19.4%
📅 குறுகிய காலம்Inflow of ₹6.85 crore improves near-term liquidity; promoter participation signals internal confidence.
📈 நீண்ட காலம்Successful conversion of warrants within 18 months will expand equity capital base by 6,85,000 shares and provide ₹20.55 crore additional cash for scaling operations.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of 6,85,000 shares upon exercise of warrants
Risk of non-exercise by warrant holders if market price stays below ₹400 over the next 18 months
👀 கவனிக்க வேண்டியவை
Track the deployment of upfront funds (₹6.85 crore) and subsequent conversion timing of the warrants into equity over the next 18 months, which will result in equity dilution.
Pelatro Limited has received ₹6.85 crore, representing the 25% upfront subscription money, for the preferential issue of 6,85,000 convertible share warrants at an issue price of ₹400 per warrant. The total proposed fundraise aggregates to ₹27.40 crore, which represents approximately 19.4% of its TTM revenue (₹141 crore) and 30.4% of its net worth (₹90 crore). The allottees include promoters Varun Menon (1,20,000 warrants) and Kiran Menon (80,000 warrants), alongside various public investors. The statutory auditor has issued a certificate confirming the receipt of funds via proper banking channels without any circulation of funds.
உச்சம் நம்பிக்கை
என்ன மாறியதுPelatro secured ₹6.85 crore upfront capital, advancing the issuance of 6.85 lakh convertible warrants priced at ₹400.
ஏன் இது முக்கியம்The ₹27.40 crore total capital injection strengthens the balance sheet (representing ~30% of net worth) and confirms promoter participation alongside external investors.
Total warrant issue size: Rs. 27,40,00,000Upfront consideration received (25%): Rs. 6,85,00,000Warrants to be allotted: 6,85,000Issue price per warrant: Rs. 400Total fundraise vs Net worth: ~30.4%Total fundraise vs TTM revenue: ~19.4%
📅 குறுகிய காலம்Confirms financial closure for the initial tranche of the preferential issue, offering positive sentiment regarding liquidity and promoter alignment.
📈 நீண்ட காலம்Provides equity growth capital for scaling products and integrating Estel, though full dilution will materialize as warrants are converted to equity shares over up to 18 months.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution upon conversion of warrants into shares
Balance 75% consideration remains contingent on warrant holders exercising conversion rights within statutory timelines
👀 கவனிக்க வேண்டியவை
Track the formal allotment of warrants and monitor the 18-month conversion window, alongside tracking the deployment of proceeds toward product integration and working capital.
Pelatro Reports Q2 FY27 PAT Up 53.5% YoY to ₹7.14 Cr on 21.6% Revenue Growth
Pelatro released its earnings call transcript for Q2 & H1 FY27, reporting strong operational expansion. Q2 revenue rose 21.6% YoY to ₹41.4 crore, while EBITDA grew 35.3% YoY to ₹10.14 crore with margins expanding to 24.5%. Q2 PAT increased 53.5% YoY to ₹7.14 crore, driven by nonlinearity in product deployments. For H1 FY27, revenue reached ₹81.62 crore (up 34.4% YoY) and PAT stood at ₹12.57 crore (up 53% YoY). The Estel division generated ₹9 crore+ in Q2 with EBITDA margins rising to ~20%, projected to converge with the core CVM division's ~23% margin within 12 months.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the detailed Q2 & H1 FY27 earnings conference call transcript held on November 05, 2026.
ஏன் இது முக்கியம்Demonstrates operating leverage and successful post-merger integration of Estel, which is delivering ~30% revenue growth and steady margin expansion.
📅 குறுகிய காலம்Transcript provides granular clarity on segment performance and working capital; reception should be positive given strong top-line and bottom-line momentum.
📈 நீண்ட காலம்Integration of agentic AI into products and upselling Estel's customer base from 1.3 to 2.5 products per customer could sustain margin expansion over the next 3-4 years.
⚠ அபாய எச்சரிக்கைகள்
Elevated receivables at ₹57 crore (DSO at upper end of normal range at 126-127 days)
Quarterly revenue lumpiness due to long sales cycles (10+ months) and deployment timelines
👀 கவனிக்க வேண்டியவை
Monitor receivables collection in upcoming quarters to ensure DSO stays within the guided 110-130 days range, alongside the pace of Estel margin convergence toward 23%.
Pelatro Limited's Board of Directors met on November 04, 2026, and approved the unaudited standalone and consolidated financial results for the half year ended September 30, 2026. The meeting concluded within 35 minutes, between 11:10 AM and 11:45 AM. Detailed numerical financial statements and limited review reports were submitted alongside the filing, though specific revenue and profit figures were not extracted in the covering letter.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுPelatro officially announced and approved its financial performance for the half year ended September 30, 2026.
ஏன் இது முக்கியம்Provides updated clarity on execution and profitability progress against the company's expected 25-30% annual growth target.
Financial period ended: செப்டம்பர் 30, 2026Meeting duration: 35 minutesTTM Revenue context: ₹141 கோடி
📅 குறுகிய காலம்Market reaction will depend on the detailed revenue and margin print in the attached financial tables relative to Q1 FY27 performance (₹40.2 Cr revenue).
📈 நீண்ட காலம்Structural trajectory relies on expanding global telecom customer accounts and launching updated Estel product versions.
⚠ அபாய எச்சரிக்கைகள்
Long sales cycles of 10+ months leading to quarterly volatility
Margin dilution risks if acquired product cross-selling stalls
👀 கவனிக்க வேண்டியவை
Review the accompanying detailed standalone and consolidated financial tables to assess half-yearly revenue run-rate against TTM revenue of ₹141 Cr and verify operating margin trends following the Estel integration.
H1 FY27 PAT Jumps 53.1% YoY to ₹12.57 Cr; Revenue Up 34.4% to ₹81.62 Cr
Pelatro Limited reported a strong H1 FY27 performance with consolidated revenue from operations rising 34.37% YoY to ₹81.62 crore compared to ₹60.74 crore in H1 FY26. Consolidated PAT for the half year grew 53.11% YoY to ₹12.57 crore, driven by solid demand across its business units. For Q2 FY27, revenue grew 21.59% YoY to ₹41.40 crore while PAT increased 53.56% YoY to ₹7.14 crore. Management confirmed that 100% of FY27 revenue is already contracted, providing high revenue visibility for the remainder of the fiscal year.
உச்சம் நம்பிக்கை
என்ன மாறியதுPelatro released its consolidated financial performance press release for Q2 and H1 FY27, highlighting >53% net profit expansion.
ஏன் இது முக்கியம்The company demonstrated healthy top-line acceleration and margin leverage across CVM and Estel divisions, supported by full revenue contract visibility for FY27.
📅 குறுகிய காலம்Earnings display robust acceleration, which should be viewed positively given the 53% growth in profitability and guaranteed contracted backlog for FY27.
📈 நீண்ட காலம்Cross-selling between the mViva CVM platform and the acquired Estel division, alongside AI-led delivery cost optimizations targeted for FY28, supports mid-term compounding if telecom client additions persist.
⚠ அபாய எச்சரிக்கைகள்
Long sales cycles (10+ months) and implementation periods (5-8 months) can induce lumpiness in future contract conversions.
👀 கவனிக்க வேண்டியவை
Track execution on the remaining contracted pipeline for H2 FY27 and monitor the commercial rollout of internal GenAI/Agentic AI initiatives expected to yield delivery cost efficiencies by FY28.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Pelatro Approves Rs 28 Cr Preferential Issue of 7 Lakh Warrants at Rs 400 Each
Pelatro Limited shareholders have approved the issuance of 7,00,000 convertible share warrants at Rs. 400 each on a preferential basis via postal ballot. The resolution was passed unanimously with 100% of the 64,97,890 valid votes cast in favour across 32 voting members. The fundraise will mobilize Rs 28 crore, representing approximately 22% of the company's TTM revenue of Rs 127 crore and 31% of its net worth (Rs 90 crore). The voting process concluded on October 21, 2026, based on a record date of September 11, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுShareholders have formally approved the preferential issuance of 7 lakh convertible warrants, paving the way for Rs 28 crore of fresh equity capital.
ஏன் இது முக்கியம்The Rs 28 crore capital infusion significantly strengthens the balance sheet (vs. existing debt of Rs 41 crore) to support product integration and growth.
Warrants to be issued: 7,00,000Issue price per warrant: Rs. 400Total fundraise value: Rs 28 croreFundraise vs TTM revenue: ~22.0%Votes in favour: 100%
📅 குறுகிய காலம்Approval is secured; market focus will turn to final regulatory clearances, allotment notices, and the upfront cash inflow.
📈 நீண்ட காலம்The additional equity provides growth capital to execute customer base expansion and complete the Estel acquisition integration without overburdening balance sheet leverage.
⚠ அபாய எச்சரிக்கைகள்
Future equity dilution upon conversion of warrants into equity shares
Execution risk on utilizing capital effectively given the long 10+ month sales cycle
👀 கவனிக்க வேண்டியவை
Track the allotment timeline, receipt of the initial 25% warrant subscription amount, and specific capital deployment towards integration or product rollouts.
Pelatro Revises Preferential Warrant Issue to ₹27.40 Cr Following NSE Observations
Pelatro Limited issued a corrigendum to its postal ballot notice following observations from the NSE regarding its proposed preferential issue of convertible warrants. The company reduced the total warrant count from 7,00,000 to 6,85,000 warrants at ₹400 each, lowering the total fundraise from ₹28.00 Cr to ₹27.40 Cr. The proposed capital raise equals ~21.6% of its TTM revenue (₹127 Cr) and ~30.4% of its net worth (₹90 Cr). Following conversion, total promoter group holding is slated to adjust from 52.62% to 49.45%.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe number of convertible share warrants offered was reduced by 15,000, bringing down the proposed preferential issue size from ₹28.00 Cr to ₹27.40 Cr due to NSE observations.
ஏன் இது முக்கியம்The fundraise injects fresh growth capital representing ~30.4% of net worth, though full conversion will lead to dilution, dropping promoter holding below 50% to 49.45%.
Revised fundraise size: Rs. 27,40,00,000Issue price per warrant: Rs. 400Total warrants to issue: 6,85,000Fundraise vs TTM revenue: ~21.6%Fundraise vs Net Worth: ~30.4%
📅 குறுகிய காலம்Shareholders have the opportunity to update their postal ballot votes prior to October 21, 2026, with minimal near-term impact aside from the minor adjustment in issue size.
📈 நீண்ட காலம்The capital supports balance sheet expansion and debt reduction (current debt at ₹41 Cr), though conversion over the 18-month window will dilute existing equity holders.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution: promoter group holding falls from 52.62% to 49.45% post-conversion
Warrant execution timeline spans up to 18 months, delaying full equity infusion
👀 கவனிக்க வேண்டியவை
Track the outcome of the postal ballot voting concluding on October 21, 2026, followed by receipt of in-principle NSE approval and initial 25% subscription inflows.
Pelatro proposes Rs 28 Cr preferential warrant issue at Rs 400 per warrant
Pelatro Limited has issued a Postal Ballot notice seeking shareholder approval to raise up to Rs 28.00 crore through the issuance of 7,00,000 convertible share warrants at Rs 400 each on a preferential basis. The proposed fundraise represents approximately 22.0% of its TTM revenue of Rs 127 crore and 31.1% of its net worth of Rs 90 crore. Proceeds are earmarked primarily for working capital requirements (Rs 21.50 crore) and general corporate purposes (Rs 6.50 crore). Promoters Kiran Menon and Varun Menon will subscribe to 2,00,000 warrants (aggregating Rs 8 crore), with overall promoter holding expected to dilute slightly from 52.62% to 51.13% post full conversion.
உச்சம் நம்பிக்கை
என்ன மாறியதுPelatro is seeking shareholder approval to raise Rs 28 crore via preferential convertible warrants to promoters and non-promoters.
ஏன் இது முக்கியம்The Rs 28 crore infusion significantly strengthens working capital liquidity (covering ~22% of TTM revenue) to support business expansion and product launches following its Estel acquisition.
Total fundraise: Rs 28,00,00,000Warrants offered: 7,00,000Issue price per warrant: Rs 400Fundraise vs TTM revenue: ~22.0%Fundraise vs Net Worth: ~31.1%Working capital allocation: Rs 21,50,00,000
📅 குறுகிய காலம்Near-term focus will be on shareholder approval via e-voting ending October 21, 2026, and warrant allotment.
📈 நீண்ட காலம்Provides key capital runway to finance lengthy enterprise sales cycles (10+ months) and scale software deployments without incurring additional debt.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of ~6.6% on expanded equity base upon full warrant conversion
Conversion risk if share price trades below warrant strike price over the 18-month exercise window
👀 கவனிக்க வேண்டியவை
Track the outcome of the postal ballot voting concluding on October 21, 2026, followed by the formal allotment date and receipt of warrant subscription money.
Pelatro Board Approves ₹28 Cr Convertible Warrant Issuance at ₹400/Share
Pelatro Limited's Board has approved a postal ballot notice to seek shareholder approval for issuing 7,00,000 convertible share warrants at ₹400 per warrant, raising up to ₹28.00 crore. The warrants are convertible into equity shares (face value ₹10) within an 18-month window from the allotment date. The proposed ₹28 crore capital infusion is sizeable, representing approximately 22% of TTM revenue (₹127 crore) and 31% of the company's net worth (₹90 crore). E-voting for the postal ballot is scheduled to commence on September 22, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved seeking shareholder approval via postal ballot to raise ₹28 crore through the issuance of 7,00,000 convertible share warrants.
ஏன் இது முக்கியம்The fundraise represents ~31% of Pelatro's ₹90 crore net worth, providing meaningful growth capital to support integration of acquisitions, debt reduction (debt at ₹41 crore), or software delivery scaling.
Total fundraise value: Rs. 28,00,00,000Number of warrants: 7,00,000Issue price per warrant: Rs. 400Exercise window: 18 மாதங்கள்Fundraise vs Net Worth: ~31.1%Fundraise vs TTM Revenue: ~22.0%
📅 குறுகிய காலம்Shareholder attention will shift to the postal ballot e-voting results starting September 22, 2026, and the disclosure of the warrant recipients.
📈 நீண்ட காலம்If successfully converted, the infusion will strengthen the balance sheet and bolster liquidity, though it will result in equity dilution over the 18-month exercise horizon.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution upon warrant exercise over the 18-month period
Allottees and specific use of proceeds not yet disclosed in the preliminary intimation
👀 கவனிக்க வேண்டியவை
Track the upcoming postal ballot notice on September 21, 2026, for specific details regarding the proposed allottees (promoter vs. non-promoter) and the stated end-use of proceeds.
50.7% Revenue Growth in Q1 FY27; PAT up 52.5% to ₹5.43 Cr
Pelatro reported a strong start to FY27 with revenue growing 50.7% YoY to ₹40.22 Cr, driven by 25.1% growth in its core CVM division and the inclusion of the Estel division. PAT increased 52.5% to ₹5.43 Cr, reflecting operating leverage as PAT growth outpaced revenue growth. However, Unbilled Revenue (UBR) remains high at ₹20 Cr, representing nearly 50% of the quarter's revenue, partly due to regulatory payment delays in specific geographies. The company maintains a conservative growth guidance of 15% while focusing on AI integration to improve margins in FY28.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully integrated the Estel acquisition and demonstrated strong organic growth in its core CVM business while maintaining a stable headcount through AI usage.
ஏன் இது முக்கியம்The strong growth and improving ROCE (22%) indicate high demand for telecom engagement software, though the high unbilled revenue highlights working capital risks inherent in emerging market telecom contracts.
📅 குறுகிய காலம்Positive sentiment expected due to strong top-line and bottom-line growth that significantly exceeds the company's 15% guidance.
📈 நீண்ட காலம்Structural growth depends on successful cross-selling of Estel products and AI-driven cost efficiencies expected to manifest in FY28.
⚠ அபாய எச்சரிக்கைகள்
High Unbilled Revenue (₹20 Cr)
Long payment cycles (8-10 months) in certain geographies
Lower margins in the Estel division
👀 கவனிக்க வேண்டியவை
Monitor the conversion of Unbilled Revenue (₹20 Cr) into cash and the margin improvement in the Estel division, which currently lags the core business at 8.72% EBITDA margin.
Pelatro Q1 FY27: Revenue up 51% to ₹40.22 Cr, PAT grows 53% YoY with 100% Revenue Visibility
Pelatro Limited reported a strong start to FY27 with consolidated revenue growing 50.69% YoY to ₹40.22 Cr, which represents approximately 31.7% of its TTM revenue. Net profit (PAT) increased 52.51% YoY to ₹5.43 Cr, driven by the core CVM division's robust 22.56% EBITDA margin. The company has secured 100% of its FY27 revenue through contracts, providing high earnings predictability. However, the recently acquired Estel division currently operates at a lower EBITDA margin of 8.72%, which management expects to normalize over the next 12-15 months.
உச்சம் நம்பிக்கை
என்ன மாறியதுPelatro has demonstrated successful scale-up post the Estel acquisition, achieving over 50% growth in both top and bottom lines while maintaining stable consolidated PAT margins at 13.49%.
ஏன் இது முக்கியம்The 100% contracted revenue visibility for FY27 significantly de-risks the near-term growth outlook, while the integration of AI (Agentic AI) into their mViva platform is positioned to drive long-term cost efficiencies and product differentiation.
Q1 FY27 Revenue: ₹40.22 கோடிQ1 வருவாய் vs TTM வருவாய்: 31.65%YoY PAT Growth: 52.51%Contracted Revenue Visibility: 100% for FY27வர்த்தக வசூலிக்கவேண்டியவை: ₹54.80 கோடிDebt-Equity Ratio: 0.13
📅 குறுகிய காலம்The stock may react positively to the strong YoY growth and the management's assurance of 100% contracted revenue for the full year.
📈 நீண்ட காலம்Structural growth depends on the successful margin expansion of the Estel division and the company's ability to maintain its 25-30% growth target through its AI-driven customer engagement platform.
⚠ அபாய எச்சரிக்கைகள்
Estel division margin dilution (8.72% vs 22.56% for CVM)
High trade receivables (₹54.80 Cr) exceeding quarterly revenue (₹40.22 Cr)
Long sales cycles (10+ months) typical of the telecom software industry
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin trajectory of the Estel division, as management expects it to reach CVM division levels within 12-15 months, and track the impact of AI-driven product launches on software development costs in FY28.
Pelatro Q1 FY27: Consolidated PAT at Rs 1.10 Cr; Subsidiary Revenue contributes Rs 18.33 Cr
Pelatro Limited reported a consolidated Profit After Tax (PAT) of Rs 1.10 Cr for the quarter ended June 30, 2026. Revenue was primarily driven by its subsidiary, Pelatro Pte. Ltd., which contributed Rs 18.33 Cr, while the Estel Technologies subsidiary added Rs 0.23 Cr. The company's consolidated net worth improved to Rs 109.88 Cr from Rs 104.00 Cr in March 2026. Total consolidated assets stood at Rs 192.54 Cr, reflecting a 4.5% increase over the previous quarter.
உச்சம் நம்பிக்கை
என்ன மாறியதுPelatro reported its Q1 FY27 financial results, marking the first quarter of the new fiscal year following the Estel acquisition.
ஏன் இது முக்கியம்The results show a slow start to the fiscal year with Q1 PAT representing only ~7.6% of the previous year's total PAT, highlighting the impact of long sales cycles.
Consolidated PAT (Q1): Rs 1.10 கோடிSubsidiary Revenue (Pelatro Pte): Rs 18.33 கோடிSubsidiary Revenue vs TTM: ~14.4%Consolidated Net Worth: Rs 109.88 கோடிமொத்தச் சொத்துகள்: Rs 192.54 கோடிStandalone PBT: Rs 0.36 கோடி
📅 குறுகிய காலம்The stock may see neutral to slightly cautious movement as the Q1 PAT run-rate is lower than the TTM average.
📈 நீண்ட காலம்Structural growth depends on achieving the 25-30% growth target through global customer expansion and successful cross-selling of the Estel product suite.
⚠ அபாய எச்சரிக்கைகள்
High revenue concentration in international subsidiaries
Long sales and implementation cycles (10+ months)
Estel subsidiary results were not reviewed by statutory auditors
👀 கவனிக்க வேண்டியவை
Monitor the execution of the Estel integration and the launch of new product versions by March 2026 to see if OPM recovers toward the 17-18% range.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
